InsiderGauge
Checking updates…
Dashboard

Meeker David Pinsider trades

In SEC Form 4 filings, Meeker David P is listed as President and CEO of Rhythm Pharmaceuticals, Inc. (RYTM). In the last 90 days, Meeker David P sold $5.13M of Rhythm Pharmaceuticals, Inc. (RYTM) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
RYTMRhythm Pharmaceuticals, Inc.President and CEO7Sep 14

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-14

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14M50,000$6.05$302,500289,258YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14S6,439$101.75Sale −$655,145282,819YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14S30,746$102.35Sale −$3,146,761252,073YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14S8,698$103.43Sale −$899,634243,375YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14S1,817$104.55Sale −$189,965241,558YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14S2,300$105.19Sale −$241,937239,258YesForm 4
RYTMRhythm Pharmaceuticals, Inc.Sep 14Sep 14M · derivative50,000$6.05$302,50015,431YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.